At a glance
- Originator Abbott Laboratories
- Class Antifungals; Methylamines; Small molecules; Tetrahydronaphthalenes
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 29 Mar 1996 Discontinued-Preclinical for Mycoses in USA (Unknown route)